2nd Quarter - Report

THE SOCIETY OF THORACIC SURGEONS for THE SOCIETY OF THORACIC SURGEONS

Firm
Client
Income
—
Expenses
$358,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medicare physician payment reform, MEDPAC, surgical global payments, health care reform, health care quality improvement, physician workforce issues, comparative clinical effectiveness research, health information technology, EHR meaningful use, EHR data blocking, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, registry access to Medicare claims data, lung cancer screenings, Agency for Healthcare Research & Quality, air quality monitoring, Center for Disease Controls Climate and Health Program, Center for Disease Controls Office of Smoking and Health, graduate medical education, electronic cigarette and cigar regulation, PTAC, meaningful use, congenital heart disease funding, unique device identifiers, medical liability reform, tobacco riders in appropriations bills, tobacco regulation in the FDA, price transparency, ECMO, Pediatric Subspecialty Loan Repayment Program, Quit Because of COVID-19 Act, A bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions, and for other purposes. (S.834), Congenital Heart Futures Reauthorization Act, surprise billing, prior authorization, Resident Physician Shortage Reduction Act (S.348/HR1763), Medicare Sequester COVID Moratorium Act (H.R.315), T21 bills, Transcatheter aortic valve replacement (TAVR), Center for Disease Control and Preventions National Center for Environmental Health funding, CDC's Climate and Health Program, Dr. Lorna Breen Health Care Provider Protection Act Support Letter (S. 610/H.R. 1667), CDC Office on Smoking and Health, Cardiovascular Advances in Research and Opportunities Legacy (CAROL) Act, Tobacco Tax Equity Act, 20th Century Cures Act 2.0, Resident Physician Shortage Reduction Act of 2021

LobbyistCovered position, as disclosed
NICHOLAS RYAN BEEK —
JULIE GALLOWAY MABEUS —
KELLY IRENE MCCONE New —
COURTNEY YOHE SAVAGE —

Contacted: Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Social Security Administration (SSA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 315 (117th), S. 348 (117th), S. 834 (117th), S. 610 (117th), H.R. 1667 (117th), H.R. 1763 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.